Heidelberg Pharma is Pharmaceuticals in Germany that focus on Heidelberg Pharma AG business. Founded in 1997. They cover business area such as Heidelberg Pharma AG, oncology, amanitin, cancer therapy, its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform, action, multiple myeloma, addition, preclinical contract research service, business division, Customer Specific Research, Diagnostics, Therapeutics.
1997
( 27 years old in 2024 )
Heidelberg Pharma AG
-
Gregor-Mendel-Straße 22
68526 Ladenburg
Germany
Private
Heidelberg Pharma AGoncologyamanitincancer therapyits proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platformactionmultiple myelomaadditionpreclinical contract research servicebusiness divisionCustomer Specific ResearchDiagnosticsTherapeutics
* We use standard office opening hours in near Heidelberg Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Heidelberg Pharma is Pharmaceuticals business from Germany that founded in 1997 (27 years old in 2024), Heidelberg Pharma business is focusing on Heidelberg Pharma AG.
Heidelberg Pharma headquarter office and corporate office address is located in Gregor-Mendel-Straße 22 68526 Ladenburg Germany.
Heidelberg Pharma was founded in Germany.
In 2024, Heidelberg Pharma is currently focus on Heidelberg Pharma AG sector.
Above is snippet of Google Trends for "Heidelberg Pharma AG" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Heidelberg Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
